semaglutide facial aging Ozempic Face”: An Emerging Drug-Related Aesthetic Concern and Its Treatment with Endotissutal Bipolar Radiofrequency (RF)—Our Experience Warning that Ozempic and Mounjaro

A 2024 study led by Wang, Volkow, and colleagues examined two cohorts totaling over 682,000 individuals with either obesity or type 2 diabetes and found the risk of new alcohol use disorder diagnoses was about 50% lower among those taking semaglutide compared to other anti-obesity or diabetes medications (Wang et al., 2024a)

Youre a patient with a specific history and specific goals, not just a name in a national database

In trials, people taking retatrutide lost an average of 24% of their body weight over 48 weeks, compared to around 15-17% with Wegovy (semaglutide) and 15-22% with Mounjaro (tirzepatide)

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates